Lightpoint Medical, a medical device company developing miniaturized cancer detection tools for robot-assisted surgery, announced today that it has completed an $8 million financing round. Read More →
Lightpoint Medical announced Wednesday that its SENSEI robotic gamma probe received the CE mark for intra-operative detection of sentinel lymph nodes. The company said the approval makes SENSEI the first robotic gamma probe to be commercially available to hospitals in Europe. Read More →
Lightpoint Medical has secured a £5 million round from backers including Envestors and Cambridge Capital Group. The startup, which develops intraoperative molecular imaging and sensing technology, plans to use the funds to boost commercial growth. https://pitchbook.com/newsletter/lightpoint-medical-shines-with-5m-investment
Lightpoint Medical Receives 2.4M Euro Grant to Support Clinical Study Aiming to Cut Breast Cancer Re-Operation Rates. Lightpoint Medical will evaluate the LightPath™ Imaging System as a means of identifying cancer in a study involving over 300 breast cancer patients involving several hospitals in the UK, Germany, and France.
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath™ Imaging System is now CE marked, enabling the launch of the device in Europe. ... "Bringing LightPath™ to market is an important milestone in our efforts to transform cancer surgery."
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath™ Imaging System is now CE marked, enabling the launch of the device in Europe. “We are delighted to have achieved the major landmark of... Read More →